Aventis Pharma today said its net profit rose by 40.16% to Rs 50.6 crore in the first quarter ended March 31, 2011, vis-a-vis the same period of the previous year.
The company had reported a net profit of Rs 36.1 crore for the same period last year, Aventis Pharma said in a filing to the Bombay Stock Exchange (BSE).
The company's net sales rose to Rs 276.3 crore for the first quarter, compared to Rs 251.4 crore in the same period of the previous year.
The company's board in its meeting held on February 16, 2011, had recommended a final dividend of Rs 23 per share of Rs 10 face value for the year ended December 31, 2010.
The board had also recommended a special one-time dividend of Rs 28 per equity share of Rs 10.
Shares of Aventis Pharma were trading at Rs 2,023 apiece on the BSE in the late afternoon today, up 5.73% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app